Common Contracts
3 similar Placement Agency Agreement contracts by Virpax Pharmaceuticals, Inc.
Placement Agency AgreementPlacement Agency Agreement • November 15th, 2024 • Virpax Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This letter (the “Agreement”) constitutes the agreement between Spartan Capital Securities, LLC (the “Placement Agent”) and Virpax Pharmaceuticals, Inc., a Delaware corporation (the “Company”), that the Placement Agent shall serve as the exclusive placement agent for the Company, on a reasonable “best efforts” basis, in connection with the proposed offering (the “Placement”) of 10,000,000 shares (the “Shares”) of common stock of the Company, par value $0.00001 per share (the “Common Stock”), and/or pre-funded warrants to purchase Shares (the “Pre-Funded Warrants” and together with the Shares, the “Securities”). The Securities actually placed by the Placement Agent are referred to herein as the “Placement Securities.” The Shares, Pre-Funded Warrants, and the shares of Common Stock underlying the Pre-Funded Warrants will be offered and sold under the Company’s registration statement on Form S-1 (File No. 333-281080). The documents executed and delivered by the Company and the Purchasers
Placement Agency AgreementPlacement Agency Agreement • October 18th, 2024 • Virpax Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Placement Agency AgreementPlacement Agency Agreement • August 13th, 2024 • Virpax Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
